Shares of Peregrine Pharmaceuticals (PPHM -2%) take a wild swing lower after opening solidly in...


Shares of Peregrine Pharmaceuticals (PPHM -2%) take a wild swing lower after opening solidly in the green this morning on the back of news that its bavituximab treatment performed well in Phase II trials.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs